Cardlytics, Inc.
DE ˙ DB ˙ US14161W1053
0,45 € ↓ -0,04 (-8,23%)
2026-06-05
DEL PRIS
SecurityDE:CYX / Cardlytics, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jane Street Group, Llc ownership in CYX / Cardlytics, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 0 shares of Cardlytics, Inc. (DE:CYX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 658,784 shares of Cardlytics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (CYX) in the form of stock options. The firm currently holds call options representing 70,600 of underlying shares valued at $74,130 USD and put options representing 16,300 of underlying shares valued at $17,115 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:CYX / Cardlytics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CARDLYTICS COM 14161W105 0 -658,784 -100.00 0 -100.00
2026-02-12 2025-12-31 13F CARDLYTICS COM 14161W105 658,784 -140,873 -17.62 758 -61.04 0.0001
2025-11-14 2025-09-30 13F CARDLYTICS COM 14161W105 799,657 637,230 392.32 1,943 627.72 0.0003
2025-08-14 2025-06-30 13F CARDLYTICS COM 14161W105 162,427 117,687 263.05 267 229.63 0.0001
2025-05-19 2025-03-31 13F/A-1 CARDLYTICS COM 14161W105 44,740 -24,097 -35.01 81 -68.24 0.0000
2025-05-14 2025-03-31 13F CARDLYTICS COM 14161W105 44,740 -24,097 81 0.0000
2025-02-14 2024-12-31 13F CARDLYTICS COM 14161W105 68,837 23,390 51.47 255 75.86 0.0001
2024-11-15 2024-09-30 13F CARDLYTICS COM 14161W105 45,447 -48,646 -51.70 145 -81.22 0.0000
2024-08-15 2024-06-30 13F CARDLYTICS COM 14161W105 94,093 -293,060 -75.70 773 -86.24 0.0002
2024-05-16 2024-03-31 13F CARDLYTICS COM 14161W105 387,153 279,844 260.78 5,610 467.71 0.0012
2024-02-15 2023-12-31 13F CARDLYTICS COM 14161W105 107,309 20,461 23.56 988 -31.01 0.0003
2023-11-15 2023-09-30 13F CARDLYTICS COM 14161W105 86,848 38,612 80.05 1,433 371.05 0.0005
2023-08-14 2023-06-30 13F CARDLYTICS COM 14161W105 48,236 1,814 3.91 305 93.63 0.0001
2023-05-16 2023-03-31 13F CARDLYTICS COM 14161W105 46,422 -7,786 -14.36 158 -49.84 0.0001
2023-02-15 2022-12-31 13F CARDLYTICS COM 14161W105 54,208 54,208 313 0.0001
2022-11-14 2022-09-30 13F CARDLYTICS COM 14161W105 0 -13,478 -100.00 0 -100.00
2022-08-16 2022-06-30 13F CARDLYTICS COM 14161W105 13,478 2,740 25.52 300 -49.15 0.0001
2022-05-17 2022-03-31 13F CARDLYTICS COM 14161W105 10,738 -2,956 -21.59 590 -34.81 0.0002
2022-02-15 2021-12-31 13F CARDLYTICS COM 14161W105 13,694 -1,960 -12.52 905 -31.13 0.0003
2021-11-16 2021-09-30 13F CARDLYTICS COM 14161W105 15,654 12,507 397.43 1,314 229.32 0.0005
2021-08-16 2021-06-30 13F CARDLYTICS COM 14161W105 3,147 -23,660 -88.26 399 -86.43 0.0002
2021-05-18 2021-03-31 13F CARDLYTICS COM 14161W105 26,807 17,977 203.59 2,941 133.23 0.0015
2021-02-17 2020-12-31 13F CARDLYTICS COM 14161W105 8,830 -9,375 -51.50 1,261 -1.87 0.0006
2020-11-17 2020-09-30 13F CARDLYTICS COM 14161W105 18,205 5,633 44.81 1,285 46.02 0.0008
2020-08-17 2020-06-30 13F CARDLYTICS COM 14161W105 12,572 6,797 117.70 880 337.81 0.0007
2020-05-15 2020-03-31 13F CARDLYTICS COM 14161W105 5,775 5,775 201 0.0002
2020-02-14 2019-12-31 13F CARDLYTICS COM 14161W105 0 -11,379 -100.00 0 -100.00
2019-11-14 2019-09-30 13F CARDLYTICS COM 14161W105 11,379 11,379 381 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F CARDLYTICS COM Call 70,600 4.44 74 -3.90 n/a n/a n/a
2026-02-12 2025-12-31 13F CARDLYTICS COM Call 67,600 397.06 78 133.33 n/a n/a n/a
2025-11-14 2025-09-30 13F CARDLYTICS COM Call 13,600 33 n/a n/a n/a
2025-02-14 2024-12-31 13F CARDLYTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-15 2024-09-30 13F CARDLYTICS COM Call 81,000 -49.28 259 -80.24 n/a n/a n/a
2024-08-15 2024-06-30 13F CARDLYTICS COM Call 159,700 125.56 1,311 27.90 n/a n/a n/a
2024-05-16 2024-03-31 13F CARDLYTICS COM Call 70,800 132.89 1,026 267.38 n/a n/a n/a
2024-02-15 2023-12-31 13F CARDLYTICS COM Call 30,400 -57.95 280 -76.59 n/a n/a n/a
2023-11-15 2023-09-30 13F CARDLYTICS COM Call 72,300 1,193 n/a n/a n/a
2023-05-15 2023-03-31 13F CARDLYTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-15 2022-12-31 13F CARDLYTICS COM Call 15,200 -47.77 88 -68.25 n/a n/a n/a
2022-11-15 2022-09-30 13F CARDLYTICS COM Call 29,100 274 n/a n/a n/a
2022-08-16 2022-06-30 13F CARDLYTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-17 2022-03-31 13F CARDLYTICS COM Call 50,800 -30.41 2,793 -42.11 n/a n/a n/a
2022-02-15 2021-12-31 13F CARDLYTICS COM Call 73,000 324.42 4,825 234.14 n/a n/a n/a
2021-11-16 2021-09-30 13F CARDLYTICS COM Call 17,200 -53.89 1,444 -69.50 n/a n/a n/a
2021-08-16 2021-06-30 13F CARDLYTICS COM Call 37,300 236.04 4,734 288.67 n/a n/a n/a
2021-05-18 2021-03-31 13F CARDLYTICS COM Call 11,100 -74.94 1,218 -80.74 n/a n/a n/a
2021-02-17 2020-12-31 13F CARDLYTICS COM Call 44,300 33.43 6,325 169.95 n/a n/a n/a
2020-11-17 2020-09-30 13F CARDLYTICS COM Call 33,200 -15.31 2,343 -14.58 n/a n/a n/a
2020-08-17 2020-06-30 13F CARDLYTICS COM Call 39,200 211.11 2,743 523.41 n/a n/a n/a
2020-05-15 2020-03-31 13F CARDLYTICS COM Call 12,600 440 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F CARDLYTICS COM Put 16,300 17 n/a n/a n/a
2026-02-12 2025-12-31 13F CARDLYTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F CARDLYTICS COM Put 63,900 155 n/a n/a n/a
2024-11-15 2024-09-30 13F CARDLYTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-15 2024-06-30 13F CARDLYTICS COM Put 18,100 -32.21 149 -61.66 n/a n/a n/a
2024-05-16 2024-03-31 13F CARDLYTICS COM Put 26,700 387 n/a n/a n/a
2024-02-15 2023-12-31 13F CARDLYTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-15 2023-09-30 13F CARDLYTICS COM Put 33,100 546 n/a n/a n/a
2023-05-15 2023-03-31 13F CARDLYTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-15 2022-12-31 13F CARDLYTICS COM Put 10,000 58 n/a n/a n/a
2022-08-16 2022-06-30 13F CARDLYTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-17 2022-03-31 13F CARDLYTICS COM Put 23,600 -22.37 1,298 -35.39 n/a n/a n/a
2022-02-15 2021-12-31 13F CARDLYTICS COM Put 30,400 -3.49 2,009 -24.02 n/a n/a n/a
2021-11-16 2021-09-30 13F CARDLYTICS COM Put 31,500 188.99 2,644 91.04 n/a n/a n/a
2021-08-16 2021-06-30 13F CARDLYTICS COM Put 10,900 289.29 1,384 350.81 n/a n/a n/a
2021-05-18 2021-03-31 13F CARDLYTICS COM Put 2,800 -59.42 307 -68.83 n/a n/a n/a
2021-02-17 2020-12-31 13F CARDLYTICS COM Put 6,900 43.75 985 190.56 n/a n/a n/a
2020-11-17 2020-09-30 13F CARDLYTICS COM Put 4,800 -44.19 339 -43.69 n/a n/a n/a
2020-08-17 2020-06-30 13F CARDLYTICS COM Put 8,600 2.38 602 104.76 n/a n/a n/a
2020-05-15 2020-03-31 13F CARDLYTICS COM Put 8,400 294 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.